Literature DB >> 5411325

Assessment of pharmacokinetic constants from postinfusion blood curves obtained after I.V. infusion.

J C Loo, S Riegelman.   

Abstract

Mesh：

Substances：

Year:  1970        PMID： 5411325     DOI： 10.1002/jps.2600590107

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  134 in total

1.  The role of the kidney in the elimination of cephapirin in man.

Authors:  B E Cabana; D R Van Harken; G H Hottendorf; J T Doluisio; W O Griffen; D W Bourne; L W Dittert
Journal:  J Pharmacokinet Biopharm       Date:  1975-12

2.  Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses.

Authors:  J R Koup; D J Greenblatt; W J Jusko; T W Smith; J Koch-Weser
Journal:  J Pharmacokinet Biopharm       Date:  1975-06

3.  Pharmacokinetic study of omeprazole in elderly healthy volunteers.

Authors:  S Landahl; T Andersson; M Larsson; B Lernfeldt; P Lundborg; C G Regårdh; E Sixt; I Skånberg
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

4.  Pharmacokinetics of FCE 22891, a new oral penem.

Authors:  A Saathoff; H Lode; B Hampel; K M Deppermann; K Borner; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

5.  The pharmacokinetics of chlormethiazole following intravenous administration in the aged.

Authors:  R L Nation; B Learoyd; J Barber; E J Triggs
Journal:  Eur J Clin Pharmacol       Date:  1976       Impact factor: 2.953

6.  Disposition kinetics in dogs of diethyldithiocarbamate, a metabolite of disulfiram.

Authors:  J Cobby; M Mayersohn; S Selliah
Journal:  J Pharmacokinet Biopharm       Date:  1978-10

Review 7.  Flip-flop pharmacokinetics--delivering a reversal of disposition: challenges and opportunities during drug development.

Authors:  Jaime A Yáñez; Connie M Remsberg; Casey L Sayre; M Laird Forrest; Neal M Davies
Journal:  Ther Deliv       Date:  2011-05

8.  Pharmacokinetics of felodipine in patients with impaired renal function.

Authors:  B Edgar; C G Regårdh; P O Attman; M Aurell; H Herlitz; G Johnsson
Journal:  Br J Clin Pharmacol       Date:  1989-01       Impact factor: 4.335

9.  Absolute bioavailability of imipramine: influence of food.

Authors:  D R Abernethyl; M Divoll; D J Greenblatt; J S Harmatz; R I Shader
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  Inhibition of soluble catechol-O-methyltransferase and single-dose pharmacokinetics after oral and intravenous administration of entacapone.

Authors:  T Keränen; A Gordin; M Karlsson; K Korpela; P J Pentikäinen; H Rita; E Schultz; L Seppälä; T Wikberg
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.